Frank Herringer - Amgen Insider

AMGN -- USA Stock  

USD 185.01  1.06  0.58%

Independent Director

Mr. Frank C. Herringer is an Independent Director of Amgen Inc. Frank C. Herringer was a director of the Board of Transamerica Corporationrationration, a financial services company, since 1986, serving as Chairman of the board of directors from 1995 to December 2015. Mr. Herringer was an executive with Transamerica for 20 years, including its Chief Executive Officer from 1991 until its acquisition by Aegon N.V., a life insurance, pensions and asset management company, in 1999, subsequently serving on Aegons Executive Board for one year. Mr. Herringer was a director of Aegon U.S. Holding Corporationrationration from 1999 until its merger into Transamerica Corporationrationration in December 2015.
Age: 74  Director Since 2004      
805-447-1000  http://www.amgen.com
Herringer received an undergraduate degree and master?s degree in business administration from Dartmouth College.

Frank Herringer Latest Insider Activity

Management Efficiency

The company has return on total asset (ROA) of 8.84 % which means that it generated profit of $8.84 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on stockholders equity (ROE) of 9.59 % meaning that it created $9.59 on every $100 dollars invested by stockholders.
The company currently holds 35.54 B in liabilities with Debt to Equity (D/E) ratio of 227.5 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Amgen has Current Ratio of 3.8 suggesting that it is liquid enough and is able to pay its financial obligations when they are due.

Similar Executives

Showing few of many executives

DIRECTOR Since

Sangeeta BhatiaVertex Pharmaceuticals Incorpor
2015
David GreenwayVertex Pharmaceuticals Incorpor
2017
Peter WendellMerck Co
2003
James BloemAllergan plc
2013
William SpenglerEndo International plc
2008
Paul RothmanMerck Co
2015
William OsbornAbbott Laboratories
2013
Todd SisitskyEndo International plc
2016
Michael GrobsteinBristol Myers Squibb Company
2007
Robert AlpernAbbott Laboratories
2008
David NortonMallinckrodt Public Limited Com
2017
Shane CookeEndo International plc
2014
Patricia RussoMerck Co
1995
Franklyn PrendergastEli Lilly and Company
1995
Pamela CraigMerck Co
2015
William HarrisonMerck Co
2009
John StrattonAbbott Laboratories
2017
Karen VousdenBristol Myers Squibb Company
2018
Jeffrey EdwardsBio Rad Laboratories
2017
Elaine UllianVertex Pharmaceuticals Incorpor
2011
Dinesh PaliwalBristol Myers Squibb Company
2013

Entity Summary

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. Amgen Inc. was founded in 1980 and is headquartered in Thousand Oaks, California. Amgen operates under Biotechnology classification in USA and traded on NASDAQ. It employs 20800 people.Amgen (AMGN) is traded on NASDAQ in USA. It is located in CALIFORNIA, U.S.A and employs 20,800 people. Amgen is listed under Pharmaceutical Products category by Fama And French industry classification.

Amgen Leadership Team

Frank Herringer, Director
Francois Carbonnel, Director
Rebecca Henderson, Director, Ph.D
Annette Such, Executive
Sanders Williams, Director
Vance Coffman, Director, Ph.D
Tyler Jacks, Director, Ph.D
Brian McNamee, President
Gregory Garland, Director
Charles Holley, Director
Esteban Santos, President
Jonathan Graham, President
Sean Harper, President, Ph.D
Ellen Kullman, Director
Frank Biondi, Director
Arvind Sood, Executive
David Meline, CFO
Ronald Sugar, Director
Stuart Tross, President
Robert Bradway, Chairman
Wanda Austin, Director
Robert Eckert, Director
Madhavan Balachandran, EVP
Lori Johnston, President
Cynthia Patton, President
Greg Garland, Director
Judith Pelham, Director
David Baltimore, Director, Ph.D
Fred Hassan, Director
David Piacquad, President
Anthony Hooper, EVP

Stock Performance Indicators

Did you try this?

Run Portfolio Optimization Now
   

Portfolio Optimization

Compute new portfolio that will generate highest expected return given your specified tolerance for risk
All  Next Launch Portfolio Optimization

Pair Correlation

Equities Pair Trading Analysis
Correlation analysis and pair trading evaluation for Amgen and IQVIA Holdings. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better risk-adjusted return
Run Pair Correlation  
Check also Trending Equities. Please also try Technical Analysis module to check basic technical indicators and analysis based on most latest market data.